EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Mechanistic and translational insights into plant-derived natural products in preclinical multiple myeloma research: Current evidence

Lulu Li, Jie Xu, Liming Yu, Jingbo Shi, Changnian Li, Jiabao Gu, Yaru Wang, Siyuan Cui

Translational Oncology · 2026-02 · 64 · 102666

DOI: 10.1016/j.tranon.2026.102666 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Oncology, 2026-02. Verfasst von Lulu Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shandong University of Traditional Chinese Medicine, Jinan, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a hematological malignancy characterized by the clonal proliferation of abnormal plasma cells, with marked heterogeneity and therapeutic refractoriness. Despite the introduction of proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), monoclonal antibodies (mAbs), and chimeric antigen receptor T-cell (CAR-T) therapy, relapse and drug resistance remain major challenges that urgently need to be addressed. Plant-derived natural products have attracted increasing attention in recent years due to their multi-target synergistic effects, demonstrating unique potential in inducing MM cell apoptosis, reversing drug resistance, and modulating the immune microenvironment-making them a rising focus in translational medicine research. In this structured narrative review, we systematically summarize the anti-myeloma mechanisms of fourteen plant-derived natural products, including plant-derived monomeric compounds (baicalein, artemisinin, curcumin, celastrol, gambogic acid, resveratrol, ginsenosides, icariin, oridonin, plumbagin, formononetin) and standardized plant extracts (Strychnos nux-vomica root extract, dandelion flavonoids, Hedyotis diffusa polysaccharides). This review highlights their multi-target regulatory effects on signaling pathways, cell cycle modulation, and immune regulation, and further discusses their potential translational value in overcoming drug resistance and optimizing combination treatment strategies. Literature was retrieved from PubMed, Web of Science, and CNKI databases, covering studies published up to January 2025. Although plant-derived natural products exhibit promising multi-target regulatory mechanisms in MM therapy, their clinical translation remains limited by poor bioavailability of single compounds and the lack of standardized extracts. Future research should integrate systems pharmacology with clinical studies to elucidate multi-component synergistic networks and develop novel targeted formulations, thereby accelerating the efficient translation of phytochemicals from bench to bedside.

Schlagwörter

Stichwörter der Autor:innen

Mechanism of actionMultiple myeloma (MM)Plant-derived natural productResearch progressTranslational research

Autor:innen und Institutionen

  • Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
  • The Third Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China. Electronic address: csytcm@126.com.

Förderung

  • Medical and Health Science and Technology Development Project of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, L., Xu, J., Yu, L., Shi, J., Li, C., Gu, J., Wang, Y., & Cui, S. (2026). Mechanistic and translational insights into plant-derived natural products in preclinical multiple myeloma research: Current evidence. Translational Oncology, 64, 102666. https://doi.org/10.1016/j.tranon.2026.102666

Vancouver

Li L, Xu J, Yu L, Shi J, Li C, Gu J, et al. Mechanistic and translational insights into plant-derived natural products in preclinical multiple myeloma research: Current evidence. Translational Oncology. 2026;64:102666. doi:10.1016/j.tranon.2026.102666

BibTeX
@article{Li2026,
  author = {Li, Lulu and Xu, Jie and Yu, Liming and Shi, Jingbo and Li, Changnian and Gu, Jiabao and Wang, Yaru and Cui, Siyuan},
  title = {Mechanistic and translational insights into plant-derived natural products in preclinical multiple myeloma research: Current evidence},
  journal = {Translational Oncology},
  year = {2026},
  volume = {64},
  pages = {102666},
  doi = {10.1016/j.tranon.2026.102666}
}
Kostenlos starten →